Dusigitumab

• Target:

  IGF-1R

• Related Pathways:

  Tyrosine Kinase/Adaptors

• Purity:

  0.965

• Bioactivity:

  Dusigitumab (MEDI573) is a fully humanised monoclonal antibody targeting IGF1/IGF2, inhibiting IGF1/IGF2-induced IGF-1R phosphorylation with an IC?? of 0.97/0.2 µg/mL, suitable for cancer research.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1204390-13-5